日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/17 | 7,300 | 7,600 | 7,300 | 7,470 | +340 | +4.8% | 322,900 |
| 2022/05/16 | 7,600 | 7,630 | 7,080 | 7,130 | -350 | -4.7% | 400,000 |
| 2022/05/13 | 7,370 | 7,550 | 7,230 | 7,480 | +110 | +1.5% | 264,000 |
| 2022/05/12 | 7,800 | 7,860 | 7,250 | 7,370 | -1,270 | -14.7% | 512,400 |
| 2022/05/11 | 8,680 | 8,710 | 8,600 | 8,640 | -50 | -0.6% | 167,500 |
| 2022/05/10 | 8,660 | 8,780 | 8,610 | 8,690 | +100 | +1.2% | 180,500 |
| 2022/05/09 | 8,810 | 8,810 | 8,570 | 8,590 | -240 | -2.7% | 192,700 |
| 2022/05/06 | 8,820 | 8,870 | 8,740 | 8,830 | -50 | -0.6% | 137,900 |
| 2022/05/02 | 8,800 | 8,910 | 8,770 | 8,880 | +70 | +0.8% | 102,000 |
| 2022/04/28 | 8,670 | 8,840 | 8,660 | 8,810 | +120 | +1.4% | 133,200 |
| 2022/04/27 | 8,580 | 8,700 | 8,520 | 8,690 | -40 | -0.5% | 385,500 |
| 2022/04/26 | 8,760 | 8,790 | 8,680 | 8,730 | +20 | +0.2% | 147,300 |
| 2022/04/25 | 8,760 | 8,780 | 8,640 | 8,710 | -190 | -2.1% | 197,200 |
| 2022/04/22 | 8,900 | 8,950 | 8,840 | 8,900 | -100 | -1.1% | 148,100 |
| 2022/04/21 | 8,880 | 9,040 | 8,860 | 9,000 | +90 | +1% | 121,600 |
| 2022/04/20 | 8,990 | 9,060 | 8,810 | 8,910 | -20 | -0.2% | 171,100 |
| 2022/04/19 | 8,860 | 9,010 | 8,860 | 8,930 | +90 | +1% | 214,400 |
| 2022/04/18 | 8,810 | 8,870 | 8,680 | 8,840 | -120 | -1.3% | 118,600 |
| 2022/04/15 | 9,130 | 9,130 | 8,920 | 8,960 | -240 | -2.6% | 148,200 |
| 2022/04/14 | 9,140 | 9,210 | 9,070 | 9,200 | +190 | +2.1% | 261,000 |
| 2022/04/13 | 8,730 | 9,050 | 8,720 | 9,010 | +160 | +1.8% | 260,800 |
| 2022/04/12 | 8,860 | 8,990 | 8,790 | 8,850 | -120 | -1.3% | 231,600 |
| 2022/04/11 | 8,730 | 8,990 | 8,710 | 8,970 | +230 | +2.6% | 286,800 |
| 2022/04/08 | 8,550 | 8,760 | 8,480 | 8,740 | +340 | +4% | 456,400 |
| 2022/04/07 | 8,050 | 8,400 | 8,050 | 8,400 | +340 | +4.2% | 220,900 |
| 2022/04/06 | 8,090 | 8,170 | 8,010 | 8,060 | -150 | -1.8% | 205,800 |
| 2022/04/05 | 8,300 | 8,330 | 8,170 | 8,210 | -110 | -1.3% | 172,800 |
| 2022/04/04 | 8,280 | 8,350 | 8,180 | 8,320 | +80 | +1% | 154,400 |
| 2022/04/01 | 8,320 | 8,390 | 8,220 | 8,240 | -90 | -1.1% | 156,800 |
| 2022/03/31 | 8,540 | 8,620 | 8,330 | 8,330 | -220 | -2.6% | 166,000 |
| 2022/03/30 | 8,740 | 8,770 | 8,430 | 8,550 | -140 | -1.6% | 147,300 |
| 2022/03/29 | 8,690 | 8,750 | 8,580 | 8,690 | +120 | +1.4% | 156,000 |
| 2022/03/28 | 8,740 | 8,740 | 8,540 | 8,570 | -130 | -1.5% | 101,500 |
| 2022/03/25 | 8,620 | 8,710 | 8,560 | 8,700 | +60 | +0.7% | 104,700 |
| 2022/03/24 | 8,710 | 8,740 | 8,560 | 8,640 | -20 | -0.2% | 150,200 |
| 2022/03/23 | 8,610 | 8,680 | 8,500 | 8,660 | +310 | +3.7% | 196,300 |
| 2022/03/22 | 8,530 | 8,610 | 8,290 | 8,350 | -50 | -0.6% | 245,700 |
| 2022/03/18 | 8,300 | 8,490 | 8,280 | 8,400 | +160 | +1.9% | 229,700 |
| 2022/03/17 | 8,470 | 8,470 | 8,230 | 8,240 | -80 | -1% | 223,900 |
| 2022/03/16 | 8,200 | 8,410 | 8,180 | 8,320 | +230 | +2.8% | 304,400 |
| 2022/03/15 | 7,810 | 8,160 | 7,780 | 8,090 | +240 | +3.1% | 190,000 |
| 2022/03/14 | 7,770 | 7,910 | 7,760 | 7,850 | +130 | +1.7% | 175,200 |
| 2022/03/11 | 7,860 | 7,950 | 7,690 | 7,720 | -210 | -2.6% | 169,500 |
| 2022/03/10 | 7,900 | 7,960 | 7,790 | 7,930 | +270 | +3.5% | 254,200 |
| 2022/03/09 | 7,780 | 7,890 | 7,640 | 7,660 | -40 | -0.5% | 198,700 |
| 2022/03/08 | 7,660 | 7,820 | 7,660 | 7,700 | +140 | +1.9% | 287,400 |
| 2022/03/07 | 7,430 | 7,630 | 7,430 | 7,560 | -80 | -1% | 183,000 |
| 2022/03/04 | 7,640 | 7,740 | 7,540 | 7,640 | +30 | +0.4% | 217,000 |
| 2022/03/03 | 7,460 | 7,650 | 7,400 | 7,610 | +230 | +3.1% | 166,100 |
| 2022/03/02 | 7,360 | 7,450 | 7,350 | 7,380 | +40 | +0.5% | 210,100 |
751～
800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
